Abstract
Previous work has shown that the lethal effects of glucocorticoids on the human lymphoblastoid cell line, CEM-C7, are antagonized by the simultaneous presence of 1-beta-D-arabinofuranosylcytosine (Ara-C). A possible cell cycle mechanism prompted further studies using flow microfluorimetry. We now report that (1) Ara-C (10-100 nM) blocks cells in S-phase and (2) the block is reversible after the drug is removed. A second treatment protocol, in which glucocorticoid is added to cells recovering from the effects of 24 h exposure to Ara-C, results in a clear synergism between the 2 drugs. This synergism is observed over a range of concentrations (5-100 nM), but is most significant at low doses, where inhibition of cell growth by Ara-C occurs but cell killing is minimal. Prior treatment with Ara-C increases the number of cells killed in the presence of steroid during the period 12-24 h after removal of the S-phase block. Combinations of Ara-C and steroid can thus be either synergistic or antagonistic, depending on the drug scheduling.
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Gledhill, R., Edwards, A. & Norman, M. Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside. Br J Cancer 47, 649–657 (1983). https://doi.org/10.1038/bjc.1983.103
Issue Date:
DOI: https://doi.org/10.1038/bjc.1983.103
- Springer Nature Limited